ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
95,306.88
-0.40%
S&P 500
6,037.59
1.06%
Dow Jones
43,325.80
0.07%
US Dollar vs Yen
157.7885
0.01%
Brent Oil
73.025
0.19%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Osmotica Pharmaceuticals PLC (OSMT) 銘柄情報

Osmotica Pharmaceuticals PLC

Osmotica Pharmaceuticals PLC (OSMT)

NASDAQ
1.11
0.00
(0.00%)
終了 12月27日 6:00AM
15分遅延
0.00
0.00
(0.00%)
取引時間後: -
15分遅延

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
1.11
買値
1.09
売値
1.15
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
1.11
始値
-
時刻
最終取引時間
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

OSMT 最新ニュース

その他のニュース

UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance

-- Fourth Quarter 2021 net sales for UPNEEQ grew by approximately 41% to $3.1 million compared to the third quarter 2021 -- -- Fourth Quarter 2022 net sales for UPNEEQ targeted to range from...

2022年1月20日
GlobeNewswire Inc.

Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance

-- Fourth Quarter 2021 net sales for UPNEEQ grew by approximately 41% to $3.1 million compared to the third quarter 2021 -- -- Fourth Quarter 2022 net sales for UPNEEQ targeted to range from...

2022年1月19日
GlobeNewswire Inc.

RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022

-- Topics include corporate name change, launch plans into the medical aesthetics market and general business updates -- -- Featured speakers include Dr. Jackie Yee and Dr. Justin Harper...

2022年1月18日
GlobeNewswire Inc.

Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022

BRIDGEWATER, N.J., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian...

2022年1月6日
GlobeNewswire Inc.

Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect Conference

BRIDGEWATER, N.J., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian...

2021年12月21日
GlobeNewswire Inc.

Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business Update

Third quarter Upneeq® product sales of $2.2 million, representing 47% growth over second quarter sales Expansion of Upneeq launch continues with introduction of Direct Dispense program in eyecare...

2021年11月16日
GlobeNewswire Inc.

Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021

BRIDGEWATER, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian...

2021年11月15日
GlobeNewswire Inc.

Osmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Update on November 15, 2021

BRIDGEWATER, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that the...

2021年11月12日
GlobeNewswire Inc.

Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public Offering

BRIDGEWATER, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that on...

2021年10月14日
GlobeNewswire Inc.

Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100 Million

BRIDGEWATER, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that it has...

2021年10月7日
GlobeNewswire Inc.
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

OSMT - Frequently Asked Questions (FAQ)

What is the current Osmotica Pharmaceuticals share price?
The current share price of Osmotica Pharmaceuticals is US$ 1.11
What is the 1 year trading range for Osmotica Pharmaceuticals share price?
Osmotica Pharmaceuticals has traded in the range of US$ 0.00 to US$ 0.00 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AIREreAlpha Tech Corporation
US$ 3.5701
(160.59%)
130.88M
SPRCSciSparc Ltd
US$ 0.50
(126.04%)
239.51M
ZCARZoomcar Holdings Inc
US$ 2.80
(95.80%)
60.3M
MGIHMillennium Group International Holdings Ltd
US$ 2.9698
(94.10%)
75.35M
SKKSKK Holdings Limited
US$ 1.35
(80.48%)
52.11M
LNKSLinkers Industries Ltd
US$ 3.295
(-65.64%)
3.65M
GTIGraphjet Technology
US$ 0.3354
(-45.02%)
22.44M
BAOSBaosheng Media Group Holdings Ltd
US$ 4.3979
(-38.06%)
1.97M
NEUPNeuphoria Therapeutics Inc
US$ 4.34
(-34.54%)
599.97k
SVRESaverOne 2014 Ltd
US$ 1.0501
(-30.46%)
1.36M
XTIAXTI Aerospace Inc
US$ 0.0398
(1.53%)
270.76M
SPRCSciSparc Ltd
US$ 0.50
(126.04%)
239.51M
COEPCoeptis Therapeutics Holdings Inc
US$ 0.213249
(50.18%)
205.2M
RGTIRigetti Computing Inc
US$ 15.445
(36.08%)
204.3M
SMXSMX Security Matters Public Company
US$ 0.3303
(51.51%)
172.17M

OSMT Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
OSMT
Osmotica Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有